Rituximab Protects Insulin Producing Cells in Diabetes (CME/CE)

Patients with new-onset type 1 diabetes were modestly better able to retain beta cell function after treatment with the B-cell depleting agent rituximab (Rituxan), researchers said.

source : www.medpagetoday.com

Related News:

• Similar Survival with Two Ovarian Cancer Strategies (CME/CE, with audio)
• Preventive Surgery Works for BRCA Mutation Carriers (CME/CE, with video)
• ESC: Novel Antiplatelet Shows Promise (CME/CE, with video)
• Antiviral Tx in Early Pregnancy Safe for Baby (CME/CE, with audio)
• Cognitive Behavioral Therapy Improves Adult ADHD (CME/CE, with video)
• Benefit, Cost at Odds in Gastric CA (CME/CE, with video)
• Binge Drinking Risky with High BP (CME/CE, with audio)
• Tai Chi Relieves Fibromyalgia (CME/CE, with video)
• Alcohol Use Before Liver Tx Key to Use Afterward (CME/CE, with audio)
• Antibiotic Sponge Flops Against Heart Surgery Infections (CME/CE, with audio)

Details :
Submited at Wednesday, November 25th, 2009 at 7:01 pm on Cardiology by chuck
Comment RSS 2.0 - leave a comment - trackback